Home > Insider Trading > Filing (0001144204-15-035560)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1535481	Matthew Duffy	C/O Cormedix Inc. 1430 Us Highway 206, Suite 200 Bedminster NJ US 07921		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.001 Par Value Per Share	Acquisiton	2015-06-02	15,000	$0.28	58,223	No	4	M	Direct
Common Stock, $0.001 Par Value Per Share	Acquisiton	2015-06-02	25,000	$0.29	83,223	No	4	M	Direct
Common Stock, $0.001 Par Value Per Share	Disposition	2015-06-04	30,000	$6.48	53,223	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	Disposition	2015-06-02	25,000	$0.00	30,000	$0.29
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	Disposition	2015-06-02	15,000	$0.00	30,000	$0.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,000		2022-01-06	No	4	M	Direct
15,000		2021-11-21	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$2.02		2024-01-09	150,000	150,000	Direct
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$2.02		2024-01-09	30,000	30,000	Direct
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$0.90		2023-03-20	100,000	100,000	Direct
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$0.68		2022-12-05	125,000	125,000	Direct
Common Stock, $0.001 Par Value Per Share	Warrant (right to purchase Common Stock)	$0.40	2012-11-13	2017-11-13	25,000	25,000	Direct
Common Stock, $0.001 Par Value Per Share	Warrant (right to purchase Common Stock)	$3.48		2015-04-30	4,884	0	Direct
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$5.62		2025-03-01	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-01-09	150,000	150,000	Direct
2024-01-09	30,000	30,000	Direct
2023-03-20	100,000	100,000	Direct
2022-12-05	125,000	125,000	Direct
2017-11-13	25,000	25,000	Direct
2015-04-30	4,884	0	Direct
2025-03-01	50,000	50,000	Direct

Footnotes

These options vested 100% on January 10, 2014.
These options vest in full on the first anniversary of the date of grant.
These options vest quarterly over two years.
These options vest as follows: (a) fifty percent (50%) on the date of issuance of the CE Mark certification for Neutrolin in Europe, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013.
On November 13, 2012, the reporting person acquired in a private placement $10,000 of (a) 9% Senior Convertible Notes, convertible into shares of the Company's common stock at a conversion price of $0.35 per share, and (b) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share.
The options vest ratably, one-third of which will vest on each of the grant date, the first anniversary and the second anniversary thereof.
The warrants were issued as part of the Company's initial public offering in March 2010 and were exercisable beginning six months after the effective date of the Company's registration statement related thereto.
The expiration date was originally 3/24/2015 and was extended to 4/30/2015.